Jazz Pharmaceuticals JAZZ Oncology — Revenue from Contract with Customer, Excluding Assessed Tax
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's oncology — revenue from contract with customer, excluding assessed tax.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's oncology — revenue from contract with customer, excluding assessed tax?
- Jazz Pharmaceuticals (JAZZ) reported oncology — revenue from contract with customer, excluding assessed tax of $333.4M in Q1 2026.
- How has Jazz Pharmaceuticals's oncology — revenue from contract with customer, excluding assessed tax changed year-over-year?
- Jazz Pharmaceuticals's oncology — revenue from contract with customer, excluding assessed tax increased by 45.3% year-over-year, from $229.4M to $333.4M.
- What is the long-term trend for Jazz Pharmaceuticals's oncology — revenue from contract with customer, excluding assessed tax?
- Over 2 years (2021 to 2023), Jazz Pharmaceuticals's oncology — revenue from contract with customer, excluding assessed tax has grown at a 17.6% compound annual growth rate (CAGR), from $733.81M to $1.02B.
- What does oncology — revenue from contract with customer, excluding assessed tax mean?
- The total net sales revenue earned specifically from the company's oncology drug portfolio.
- How do you interpret oncology — revenue from contract with customer, excluding assessed tax?
- An increase indicates successful market penetration, strong demand for oncology products, or effective pricing strategies, while a decrease may signal increased competition, patent expirations, or loss of market share in the oncology segment.
- How does oncology — revenue from contract with customer, excluding assessed tax compare across companies?
- Comparable to oncology-specific revenue segments reported by other biopharmaceutical companies, often benchmarked against total oncology franchise growth rates across the industry.